MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation, a medical device company, researches, develops, and commercializes transcatheter and surgical solutions for structural heart diseases in the People's Republic of China. It offers Vitaflow Aortic Valve System, Alw…
Medical - Devices
CN, Shanghai [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | 6.79 | -22.46 | -24.10 | |
| Graham Fair Price | 0.00 | 1.17 | 1.17 | |
| PEG | inf | 0.00 | -0.10 | |
| Price/Book | -5.68 | 1.49 | 1.58 | |
| Price/Cash Flow | 5.68 | -76.64 | -81.26 | |
| Prices/Earnings | 5.68 | -5.94 | -6.30 | |
| Price/Sales | -5.68 | 43.44 | 46.06 | |
| Price/FCF | 5.68 | -76.64 | -81.26 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 0.00 | 0.71 | 0.71 | |
| Operating Margin | 0.00 | -1.40 | -1.40 | |
| ROA | 0.00 | -0.06 | -0.06 | |
| ROE | -0.06 | -0.06 | 0.00 | |
| ROIC | -0.05 | -0.05 | 1.19 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | 0.68 | -0.49 | 38.02 | |
| Dividends QOQ | 0.00 | 0.00 | 0.00 | |
| EBIT QOQ | -0.25 | 0.00 | inf | |
| EPS QOQ | -0.63 | 0.00 | inf | |
| FCF QOQ | 0.37 | 0.00 | inf | |
| Revenue QOQ | -0.09 | 0.00 | inf | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Positive
Fundamentals
Leverage & Liquidity
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 475.99 | 475.99 | 0.00 | |
| Days Sales Outstanding (DSO) | 113.78 | 113.78 | 0.00 | |
| Inventory Turnover | 0.19 | 0.19 | 0.00 | |
| Debt/Capitalization | 0.02 | 0.03 | 66.16 | |
| Quick Ratio | 9.69 | 6.07 | -37.34 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Book Value | 0.99 | 0.99 | 0.00 | |
| Cash | 0.75 | 0.45 | -39.46 | |
| Capex | < 0.005 | < 0.005 | 0.00 | |
| Free Cash Flow | -0.02 | -0.02 | 0.00 | |
| Revenue | 0.03 | 0.03 | 0.00 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Bad
Fundamentals
Financial Health
06 - Financial Health ·
Bad